Treatment of lesions with a high risk of stenosis. Comparative study in 300 patients of rapamycin- and paclitaxel-eluting polymer-based stents, and bare metal stents;Tratamiento de lesiones con alto riesgo de reestenosis. Estudio comparativo en 300 pacientes del stent liberador de rapamicina, el stent con polímero liberador de paclitaxel y el stent convencional

Revista Espanola de Cardiologia

Volumn 58, Issue 3, 2005, Pages 262-269

  de la Torre Hernández, José M ^a   Sainz Laso, Fermín ^a   Ruisánchez, Cristina ^a   Zueco, Javier ^a   Figueroa, Álvaro ^a   Colman, Thierry ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Coronary lesion; Restenosis; Stent

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY ARTERY THROMBOSIS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IN-STENT RESTENOSIS; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RESTENOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 17144395914     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072473     Document Type: Article

References (34)

1. Serruys PW, Unger F, Sousa E, Jatene A, Bonnier HJRM, Schonberger JPAM, et al, for the ARTS study group. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117-24.
2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al, for the RAVEL study group. A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.
3. Moses J, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. for the SIRIUS investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.
4. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093-9.
5. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. Six and twelve month results from a randomized, double blind trial on a slow release paclitaxel eluting stent for de novo coronary lesions (TAXUS I). Circulation. 2003;107:38-42.
6. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31.
7. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004;109:1942-7.
8. Degertekin M, Regar E, Tanabe K, Smits PC, Van der Giessen WJ, Carlier SG, et al. Sirolimus eluting stent for treatment of complex in stent restenosis: The first clinical experience. J Am Coll Cardiol. 2003;41:184-9.
9. Tanabe K, Serruys PW, Grabe E, Smits PC, Selbach G, Van der Giessen WJ, et al. TAXUS III. In stent restenosis treated with stent based delivery of paclitaxel incorporated in a slow release polymer formulation. Circulation. 2003;107:559-64.
10. Radke PW, Kobella S, Kaiser A, Franke A, Schubert D, Grube E, et al. Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy. Eur Heart J. 2004;25:920-5.
11. Li SS, So YC, Wong CH, Yiu SF, Chan KT. Treatment of long, diffuse in-stent restenosis with sirolimus eluting stents. J Invasive Cardiol. 2004;16:81-3.
12. Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis C, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol. 2004;43:1954-8.
13. Lemos PA, Arampatzis CA, Saia F, Hoye A, Degertekin M, Tanabe K, et al. Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry). Am J Cardiol. 2004;93:633-6.
14. Lemos PA, Serruys PW, Van Domburg RT, Saia F, Arampatzis CA, Hoye A, et al. Unrestricted utilization of sirolimus eluting stents compared with conventional bare metal stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004; 109:190-5.
15. Ruiz-Nodar JM, Frutos A, Carrillo P, Morillas P, Valero R, Rodríguez JA, et al. Utilización del stent recubierto de rapamicina en la revascularización de lesiones complejas: estudio con seguimiento clínico y angiográfico. Rev Esp Cardiol. 2004;57:123-9
16. De la Torre Hernández JM, Burgos V, González-Enríquez S, Cobo M, Zueco J, Figueroa A, et al. Stent liberador de rapamicina en el tratamiento de lesiones coronarias con alto riesgo de reestenosis. Seguimiento clínico a 6 meses de los primeros 100 pacientes. Rev Esp Cardiol. 2004;57:116-22.
17. Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann FJ, Schomig A. Influence of lesion length on resterrosis after coronary stent placement. Am J Cardiol. 1999;83:1617-22.
18. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as air independent predictor of restenosis. J Am Coll Cardiol. 1999;34:651-9.
19. Doucet S, Schalig MJ, Vrolix MCM, Hilton D, Chenu P, De Bruyne B, et al. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation. 2001;104:2029-33
20. Kastrati A, Schomig A, Dirschinger J, Mehilli J, Dotzer F, Von Welser N, et al. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. Circulation. 2000;102:2593-8.
21. Koning R, Eltchaninoff H, Commeau P, Khalife K, Gilard M, Lipiecki J, et al. Stent placement compared with balloon angioplasty for small coronary arteries: In hospital and 6-month clinical and angiographic results. Circulation. 2001;104:1604-8.
22. Moer R, Myreng Y, Moldstad P, Albertsson P, Gunnes P, Lindvall B, et al. Stenting in small coroanry arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent. J Am Coll Cardiol. 2001;38:1598-603.
23. García E, Gómez-Recio M, Moreno R, Pasalodos J, Bethancourt A, Zueco J, et al. Stent reduces restenosis in small vessels. Results of the RAP study [abstract). J Am Coll Cardiol. 2001;37: 32-4.
24. Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino, M, Fontanelli A, et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: Results from the GISSOC trial. J Am Coll Cardiol. 1998;32:90-6.
25. Buller CE, Dzavik V, Carere RG, Mancini GBJ, Barbeau G, Lazzam C, et al. for the TOSCA investigators. Primary stenting versus balloon angioplasty in occluded coronary arteries. The total occlusion study of Canada (TOSCA) Circulation. 1999;100:236-42.
26. Sievert H, Rohde S, Utech A, Schulze R, Scherer D, Merle H, et al. Stent or angioplasty after recanalization of chronic coronary occlusions? The SARECCO trial. Am J Cardiol. 1999;84:386-90.
27. Lotan C, Rozenman Y, Hendler A, Turgeman Y, Ayzenberg O, Beyar R, et al. Stents in total occlusion for restenosis prevention. The multicentre randomized STOP study. Eur Heart J. 2000;21:1960-6
28. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, López-Mínguez JR, et al. for the RIBS study. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol. 2003;42:796-805.
29. Ruygrok PN, Melkert R, Morel MA, Ormiston JA, Bär FW, Fernández-Avilès F, et al. Does angiography six months after coronary intervention influence management and outcome? J Am Coll Cardiol. 1999;34:1507-11.
30. Hill RA, Dundar Y, Bakhai A, Dickson R, Walley T. Drug-eluting stents: an early systematic review to inform policy. Eur Heart J. 2004;25;902-19.
31. López-Palop R, Moreu J, Fernández-Vázquez F, Hernández Antolín R. Registro Español de Hemodinámica y Cardiología Intervencionista. XIII Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2003). Rev Esp Cardiol. 2004;57:1076-89.
32. De la Torre Hernández JM, Burgos V, Pérez T, Sainz-Laso F, Figueroa A, Zueco J, et al. Respuesta inflamatoria tras implante de stents convencionales y stents de rapamicina: implicaciones pronósticas [abstract]. Rev Esp Cardiol, 2004;57 Supl 2:166.
33. Singh M, Gersh BJ, McClelland RL, Ho KKL, Willerson JT, Penny WF, et al. Clinical and Angiographic Predictors of Restenosis After Percutaneous Coronary Intervention: Insights From the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) Trial. Circulation. 2004;109:2727-31.
34. Colombo A, Iakovou I. Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J. 2004;25:895-7.